ACP Journal Club. In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines. [electronic resource]
- Annals of internal medicine Jun 2015
- JC8 p. digital
Publication Type: Journal Article; Comment
1539-3704
10.7326/ACPJC-2015-162-12-008 doi
Female Humans Immunosuppressive Agents--therapeutic use Influenza Vaccines--therapeutic use Male Multiple Sclerosis--drug therapy Propylene Glycols--therapeutic use Sphingosine--analogs & derivatives Vaccination